Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Immune recognition of OxLDL in atherosclerosis
John F. Kearney
John F. Kearney
Published June 15, 2000
Citation Information: J Clin Invest. 2000;105(12):1683-1685. https://doi.org/10.1172/JCI10426.
View: Text | PDF
Commentary Article has an altmetric score of 7

Immune recognition of OxLDL in atherosclerosis

  • Text
  • PDF
Abstract

Authors

John F. Kearney

×

Total citations by year

Year: 2021 2016 2014 2013 2012 2010 2009 2007 2004 2002 2001 Total
Citations: 1 1 3 1 1 1 1 1 2 1 1 14
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (14)

Title and authors Publication Year
B Cells in Atherosclerosis
T Pattarabanjird, C Li, C McNamara
JACC: Basic to Translational Science 2021
Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease
PI Lobo
Frontiers in immunology 2016
Natural Anti-Intestinal Goblet Cell Autoantibody Production from Marginal Zone B Cells
D Ichikawa, M Asano, SA Shinton, J Brill-Dashoff, AM Formica, A Velcich, RR Hardy, K Hayakawa
Journal of immunology (Baltimore, Md. : 1950) 2014
Carbohydrate-Mimetic Peptides for Pan Anti-Tumor Responses
T Kieber-Emmons, S Saha, A Pashov, B Monzavi-Karbassi, R Murali
Frontiers in immunology 2014
Low levels of natural IgM antibodies against phosphorylcholine are independently associated with vascular remodeling in patients with coronary artery disease
CA Gleissner, C Erbel, J Haeussler, M Akhavanpoor, G Domschke, F Linden, AO Doesch, G Conradson, SJ Buss, NP Hofmann, G Gitsioudis, HA Katus, G Korosoglou
Clinical Research in Cardiology 2014
B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance
DA Winer, S Winer, MH Chng, L Shen, EG Engleman
Cellular and Molecular Life Sciences 2013
B lymphocytes as emerging mediators of insulin resistance
DA Winer, S Winer, L Shen, MH Chng, EG Engleman
International Journal of Obesity Supplements 2012
Adaptive immunity and adipose tissue biology
DA Kaminski, TD Randall
Trends in Immunology 2010
Oxidation-specific Epitopes are Dominant Targets of Innate Natural Antibodies
Meng-Yun Chou, Linda Fogelstrand, Karsten Hartvigsen, Lotte F Hansen, Douglas Woelkers, Peter X Shaw, Jeomil Choi, Thomas Perkmann, Fredrik Bäckhed, Yury I Miller, Sohvi Hörkkö, Maripat Corr, Joseph L Witztum and Christoph J Binder
Journal of Clinical Investigation 2009
Innate and adaptive immune response to apoptotic cells
Y Peng, DA Martin, J Kenkel, K Zhang, CA Ogden, KB Elkon
Journal of Autoimmunity 2007
IL-5 links adaptive and natural immunity specific for epitopes of Oxidized LDL and protects from atherosclerosis
Christoph J. Binder, Karsten Hartvigsen, Mi-Kyung Chang, Marina Miller, David Broide, Wulf Palinski, Linda K. Curtiss, Maripat Corr, Joseph L. Witztum
Journal of Clinical Investigation 2004
Natural antibodies and the autoimmunity of atherosclerosis
CJ Binder, GJ Silverman
Springer Seminars in Immunopathology 2004
C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids
MK Chang, CJ Binder, M Torzewski, JL Witztum
Proceedings of the National Academy of Sciences 2002
Phosphorylcholine-Dependent Cross-Reactivity between Dental Plaque Bacteria and Oxidized Low-Density Lipoproteins
RN Moore, HA Schenkein, CR Berry, D Purkall, JA Burmeister, CN Brooks, JG Tew
Infection and immunity 2001

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
Referenced in 2 patents
26 readers on Mendeley
See more details